|
1
|
Woo HD, Lee J, Choi IJ, Kim CG, Lee JY,
Kwon O and Kim J: Dietary flavonoids and gastric cancer risk in a
Korean population. Nutrients. 6:4961–4973. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yan S, Li B, Bai ZZ, Wu JQ, Xie DW, Ma YC,
Ma XX, Zhao JH and Guo XJ: Clinical epidemiology of gastric cancer
in Hehuang valley of China: A 10-year epidemiological study of
gastric cancer. World J Gastroenterol. 20:10486–10494. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murray MJ and Nicholson JC: α-Fetoprotein.
Arch Dis Child Educ Pract Ed. 96:141–147. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Osada M, Aishima S, Hirahashi M, Takizawa
N, Takahashi S, Nakamura K, Tanaka M, Maehara Y, Takayanagi R and
Oda Y: Combination of hepatocellular markers is useful for
prognostication in gastric hepatoid adenocarcinoma. Hum Pathol.
45:1243–1250. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Shimada H, Noie T, Ohashi M, Oba K and
Takahashi Y: Clinical significance of serum tumor markers for
gastric cancer: A systematic review of literature by the Task Force
of the Japanese Gastric Cancer Association. Gastric Cancer.
17:26–33. 2014. View Article : Google Scholar
|
|
7
|
Yao DF, Dong ZZ and Yao M: Specific
molecular markers in hepatocellular carcinoma. Hepatobiliary
Pancreat Dis Int. 6:241–247. 2007.PubMed/NCBI
|
|
8
|
Hirajima S, Komatsu S, Ichikawa D, Kubota
T, Okamoto K, Shiozaki A, Fujiwara H, Konishi H, Ikoma H and Otsuji
E: Liver metastasis is the only independent prognostic factor in
AFP-producing gastric cancer. World J Gastroenterol. 19:6055–6061.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Peng YF, Shi YH, Ding ZB, Ke AW, Gu CY,
Hui B, Zhou J, Qiu SJ, Dai Z and Fan J: Autophagy inhibition
suppresses pulmonary metastasis of HCC in mice via impairing
anoikis resistance and colonization of HCC cells. Autophagy.
9:2056–2068. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lu S, Yu L, Mu Y, Ma J, Tian J, Xu W and
Wang H: Role and mechanism of Twist1 in modulating the
chemosensitivity of FaDu cells. Mol Med Rep. 10:53–60.
2014.PubMed/NCBI
|
|
11
|
Yu L, Lu S, Tian J, Ma J, Li J, Wang H and
Xu W: TWIST expression in hypopharyngeal cancer and the mechanism
of TWIST-induced promotion of metastasis. Oncol Rep. 27:416–422.
2012.
|
|
12
|
Ishigami S, Natsugoe S, Nakashima H,
Tokuda K, Nakajo A, Okumura H, Matsumoto M, Nakashima S, Hokita S
and Aikou T: Biological aggressiveness of alpha-fetoprotein
(AFP)-positive gastric cancer. Hepatogastroenterology. 53:338–341.
2006.PubMed/NCBI
|
|
13
|
Barranco SC, Townsend CM Jr, Casartelli C,
Macik BG, Burger NL, Boerwinkle WR and Gourley WK: Establishment
and characterization of an in vitro model system for human
adenocarcinoma of the stomach. Cancer Res. 43:1703–1709.
1983.PubMed/NCBI
|
|
14
|
Rac J, Haas F, Schumacher A, Middeldorp
JM, Delecluse HJ, Speck RF, Bernasconi M and Nadal D: Telomerase
activity impacts on Epstein-Barr virus infection of AGS cells. PLoS
One. 10:e01236452015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shen XJ, Zhang H, Tang GS, Wang XD, Zheng
R, Wang Y, Zhu Y, Xue XC and Bi JW: Caveolin-1 is a modulator of
fibroblast activation and a potential biomarker for gastric cancer.
Int J Biol Sci. 11:370–379. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan TM, Liang RY, Chueh PJ and Chuang SM:
Role of ribophorin II in the response to anticancer drugs in
gastric cancer cell lines. Oncol Lett. 9:1861–1868. 2015.PubMed/NCBI
|
|
17
|
Chen J, Röcken C, Treiber G,
Jentsch-Ulrich K, Malfertheiner P and Ebert MP: Clinical
implications of alpha-fetoprotein expression in gastric
adenocarcinoma. Dig Dis. 21:357–362. 2003. View Article : Google Scholar
|
|
18
|
Yu W, Qiao Y, Tang X, Ma L, Wang Y, Zhang
X, Weng W, Pan Q, Yu Y, Sun F, et al: Tumor suppressor long
non-coding RNA, MT1DP is negatively regulated by YAP and Runx2 to
inhibit FoxA1 in liver cancer cells. Cell Signal. 26:2961–2968.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Derouet MF, Liu G and Darling GE: MiR-145
expression accelerates esophageal adenocarcinoma progression by
enhancing cell invasion and anoikis resistance. PLoS One.
9:e1155892014. View Article : Google Scholar
|
|
20
|
Pajak B, Gajkowska B and Orzechowski A:
Molecular basis of parthenolide-dependent proapoptotic activity in
cancer cells. Folia Histochem Cytobiol. 46:129–135. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Debierre-Grockiego F: Anti-apoptotic role
of STAT5 in haematopoietic cells and in the pathogenesis of
malignancies. Apoptosis. 9:717–728. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Hardwick JM and Soane L: Multiple
functions of BCL-2 family proteins. Cold Spring Harb Perspect Biol.
5:a0087222013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Qin S, Yang C, Wang X, Xu C, Li S, Zhang B
and Ren H: Overexpression of Smac promotes cisplatin-induced
apoptosis by activating caspase-3 and caspase-9 in lung cancer A549
cells. Cancer Biother Radiopharm. 28:177–182. 2013. View Article : Google Scholar
|
